Global Data-Independent Acquisition (DIA) Quantitative Proteomics Market Strategic Research Report

Scope of the Report

The global Data-Independent Acquisition (DIA) Quantitative Proteomics market size is predicted to grow from US$ 8,517 million in 2025 to US$ 17,160 million in 2032; it is expected to grow at a CAGR of 10.7% from 2026 to 2032.

Data-Independent Acquisition (DIA) is a novel mass spectrometry data acquisition method developed in recent years. Current popular proteomics research techniques such as iTRAQ, TMT, Label-free, and SILAC utilize data-dependent acquisition (DDA), a method in which secondary mass spectrometry signals are collected based on the intensity of primary mass spectrometry signals. Stronger ion signals are selected for secondary acquisition, while weaker signals are discarded, resulting in the loss of secondary information from weak signals.DIA technology combines the high-throughput nature of traditional proteomics shotgun methods with the accurate quantification capabilities of the gold standard PRM (Parallel Reaction Monitoring) method. It was recognized by Nature Methods as a noteworthy technology in 2015. Presently, DIA quantitative proteomics includes two detection techniques: 3D DIA and 4D DIA. 3D DIA employs the Thermo Scientific QE series mass spectrometers, a classic choice for proteomics analysis due to its high peptide on-column loading capacity (ranging from 1-5 μg of peptides). On the other hand, 4D DIA employs the TIMS TOF mass spectrometers from Bruker, which enhances sensitivity and detection capabilities compared to the classical 3D technology, resulting in higher protein and peptide detection yields from the same sample.Data-Independent Acquisition (DIA) proteomics technology is applicable to nearly all sample types, allowing unbiased collection of all information within samples. It offers a superior solution for achieving high coverage, accuracy, and in-depth analysis of proteomes. DIA is particularly well-suited for analyzing disease-related samples rich in biological information, providing a significant resource for biomarker discovery, molecular typing, disease mechanism investigation, and more. By comparing differences in protein composition among different groups or states, this approach enables systematic studies of diseases, facilitating the development of precision therapies.

Global key Data-Independent Acquisition (DIA) Quantitative Proteomics players cover Creative Dynamics Inc (Creative Proteomics), MtoZ-Biolabs Inc., CD Genomics, AxisPharm, BGI Genomics, etc.

This report presents a comprehensive overview of the global Data-Independent Acquisition (DIA) Quantitative Proteomics market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 4D DIA
• 3D DIA

Segment by Application

• Medicine
• Plants
• Animal Husbandry
• Microbiology

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Data-Independent Acquisition (DIA) Quantitative Proteomics market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Medicine, Plants, Animal Husbandry evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact